文献速递乳腺乳腺X线US

数字乳腺X线摄影联合全自动乳腺超声全阅片与联合ABUS人工智能计算机辅助诊断引导的选择性阅片的乳腺癌筛查比较

Comparison of Digital Mammography Plus Full ABUS Review and Digital Mammography Plus Selective ABUS Review Guided by ABUS Artificial Intelligence-Computer-Aided Diagnosis for Breast Cancer Screening.
PubMed 文献 · Korean J Radiol · 2026-01-01

本回顾性研究纳入2022年3月至2023年3月接受数字乳腺X线摄影(DM)和自动乳腺超声(ABUS)筛查的无症状女性2275例,比较放射科医生全阅ABUS(DM+ABUS_radiologist)与仅对DM阳性或ABUS AI-CAD标记病例进行选择性阅片(DM+ABUS_AI-CAD)两种策略。结果显示选择性策略将异常解读率从16.7%降至7.3%、特异度从83.7%提高到93.1%(均P<0.001),癌检出率(4.8/1000)和敏感度(91.7%)与全阅片策略无显著差异(均P>0.999)。

要点

  • DM+ABUS_AI-CAD策略仅需放射科医生复阅16.0%(365/2275)的检查,其余84.0%在DM报告和ABUS AI-CAD均为阴性时判为阴性。
  • 与DM+ABUS_radiologist相比,DM+ABUS_AI-CAD将异常解读率从16.7%降至7.3%,特异度从83.7%升至93.1%(均P<0.001)。
  • 两种策略的癌检出率(4.4/1000 vs 4.8/1000)和敏感度(83.3% vs 91.7%)无显著差异(均P>0.999)。

核心结论

  • AI-CAD辅助的选择性ABUS阅片策略可减少不必要的召回并提高特异度,可能有助于优化阅片优先级、减少阅片工作量,同时维持癌检出性能。

研究设计与样本

  • 回顾性研究,纳入2022年3月至2023年3月接受DM和ABUS筛查的无症状女性2275例(平均年龄56.1±8.6岁),以临床放射学报告中的放射科医生独立解读(DM+ABUS_radiologist)为对照,模拟DM+ABUS_AI-CAD选择性阅片策略。

诊断标准与关键数值

  • DM+ABUS_radiologist组敏感度83.3%(10/12;95%CI 51.6-97.9),癌检出率4.4/1000(10/2275;95%CI 2.1-8.1),异常解读率16.7%(379/2275;95%CI 15.1-18.3)。
  • DM+ABUS_AI-CAD组敏感度91.7%(11/12),癌检出率4.8/1000,异常解读率7.3%(167/2275),特异度93.1%(2107/2263)。
  • DM+ABUS_radiologist组特异度83.7%(1894/2263)。
  • DM+ABUS_AI-CAD将84.0%(1910/2275)的检查判为DM和ABUS AI-CAD双阴性,仅16.0%(365/2275)需放射科医生复阅。
  • 两组敏感度、癌检出率比较均P>0.999,异常解读率和特异度比较均P<0.001(McNemar检验)。

临床应用与阅片要点

  • 在ABUS筛查阅片中,可参考选择性阅片流程:DM报告阳性或ABUS AI-CAD标记的病例才交由放射科医生复阅,双阴性病例直接判为阴性。
  • 该策略可能帮助优化阅片优先级并减少阅片工作量,同时维持癌检出性能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare two breast cancer screening strategies, digital mammography (DM) plus radiologist-interpreted automated breast ultrasound (ABUS) and DM plus selective ABUS review, in which only examinations positive for DM or flagged by ABUS artificial intelligence-computer-aided diagnosis (AI-CAD) were reviewed by radiologists.

MATERIALS AND METHODS: This retrospective study included asymptomatic women who underwent DM and ABUS screening for breast cancer between March 2022 and March 2023. The radiologists' interpretations of DM and ABUS without AI assistance (DM + ABUS_radiologist) were collected from the clinical radiology reports. A selective DM plus ABUS reading strategy was simulated, in which only cases interpreted as positive in the radiologist's DM report or flagged by retrospectively applied ABUS AI-CAD were triaged for further evaluation through a full review by radiologists (DM + ABUS_AI-CAD). The cancer detection rate (CDR), sensitivity, specificity, and abnormal interpretation rate (AIR) were calculated and compared between DM + ABUS_radiologist and DM + ABUS_AI-CAD groups using the McNemar's test.

RESULTS: Among 2,275 women (mean age, 56.1 ± 8.6 years), 12 cancers were diagnosed. The sensitivity, CDR and AIR for DM + ABUS_radiologist was 83.3% (10/12; 95% confidence interval [CI]: 51.6-97.9), 4.4 (10/2,275; 95% CI: 2.1-8.1) per 1,000 screening examinations and 16.7% (379/2,275; 95% CI: 15.1-18.3), respectively. DM + ABUS_AI-CAD triaged 84.0% (1,910/2,275) of the examinations as negative in both DM reports and retrospectively applied ABUS AI-CAD, requiring radiologist reassessment in only 16.0% (365/2,275). This approach reduced the AIR to 7.3% (167/2,275) and improved the specificity from 83.7% (1,894/2,263) to 93.1% (2,107/2,263) (all P < 0.001), while maintaining a CDR of 4.8 per 1,000 and a sensitivity of 91.7% (11/12) (all P > 0.999), compared to the DM + ABUS-radiologist.

CONCLUSION: An AI-CAD-assisted selective ABUS reading strategy reduces unnecessary recalls and improves specificity, which may help optimize reading priorities and reduce the reading workload while maintaining cancer detection performance.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Youn I, Ha SM, Jang MJ, et al. Comparison of Digital Mammography Plus Full ABUS Review and Digital Mammography Plus Selective ABUS Review Guided by ABUS Artificial Intelligence-Computer-Aided Diagnosis for Breast Cancer Screening. Korean J Radiol. 2026. PMID: 41592549. doi:10.3348/kjr.2025.1335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。